Literature DB >> 20940404

Transforming properties of 8p11-12 amplified genes in human breast cancer.

Zeng-Quan Yang1, Gang Liu, Aliccia Bollig-Fischer, Craig N Giroux, Stephen P Ethier.   

Abstract

Amplification of the 8p11-12 region has been found in about 15% of human breast cancers and is associated with poor prognosis. Earlier, we used genomic analysis of copy number and gene expression to perform a detailed analysis of the 8p11-12 amplicon to identify candidate oncogenes in breast cancer. We identified 21 candidate genes and provided evidence that three genes, namely, LSM-1, TC-1, and BAG4, have transforming properties when overexpressed. In the present study, we systematically investigated the transforming properties of 13 newly identified 8p11-12 candidate oncogenes in vitro. WHSC1L1, DDHD2, and ERLIN2 were most potently transforming oncogenes based on the number of altered phenotypes expressed by the cells. WHSC1L1 contains a PWWP-domain that is a methyl-lysine recognition motif involved in histone code modification and epigenetic regulation of gene expression. Knockdown of WHSC1L1 in 8p11-12-amplified breast cancer cells resulted in profound loss of growth and survival of these cells. Further, we identified several WHSC1L1 target genes, one of which is iroquois homeobox 3 gene (IRX3), a member of the Iroquois homeobox transcription factor family. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940404      PMCID: PMC3089754          DOI: 10.1158/0008-5472.CAN-10-1013

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

Authors:  Roberto Rosati; Roberta La Starza; Angelo Veronese; Ana Aventin; Christine Schwienbacher; Teresa Vallespi; Massimo Negrini; Massimo F Martelli; Cristina Mecucci
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

2.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

3.  NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.

Authors:  P O Angrand; F Apiou; A F Stewart; B Dutrillaux; R Losson; P Chambon
Journal:  Genomics       Date:  2001-05-15       Impact factor: 5.736

4.  WHSC1L1, on human chromosome 8p11.2, closely resembles WHSC1 and maps to a duplicated region shared with 4p16.3.

Authors:  I Stec; G J van Ommen; J T den Dunnen
Journal:  Genomics       Date:  2001-08       Impact factor: 5.736

Review 5.  HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer.

Authors:  Carlos L Arteaga; Stacy L Moulder; F Michael Yakes
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

6.  Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.

Authors:  Michael E Ray; Zeng Quan Yang; Donna Albertson; Celina G Kleer; Joseph G Washburn; Jill A Macoska; Stephen P Ethier
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

Review 7.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

Review 8.  Chromosome aberrations in solid tumors.

Authors:  Donna G Albertson; Colin Collins; Frank McCormick; Joe W Gray
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

9.  Molecular cytogenetic analysis of 11 new breast cancer cell lines.

Authors:  F Forozan; R Veldman; C A Ammerman; N Z Parsa; A Kallioniemi; O P Kallioniemi; S P Ethier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

10.  FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

Authors:  Nicholas Turner; Alex Pearson; Rachel Sharpe; Maryou Lambros; Felipe Geyer; Maria A Lopez-Garcia; Rachael Natrajan; Caterina Marchio; Elizabeth Iorns; Alan Mackay; Cheryl Gillett; Anita Grigoriadis; Andrew Tutt; Jorge S Reis-Filho; Alan Ashworth
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

View more
  44 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

2.  An open and shut case for the role of NSD proteins as oncogenes.

Authors:  Agda Karina Lucio-Eterovic; Phillip B Carpenter
Journal:  Transcription       Date:  2011-07

Review 3.  H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.

Authors:  David S Rogawski; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2016-08-22       Impact factor: 3.808

4.  Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin.

Authors:  Derek H Jones; Douglas I Lin
Journal:  Mol Clin Oncol       Date:  2017-06-08

5.  Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.

Authors:  Brittany Turner-Ivey; Ericka L Smith; Alex C Rutkovsky; Laura S Spruill; Jamie N Mills; Stephen P Ethier
Journal:  Breast Cancer Res Treat       Date:  2017-05-08       Impact factor: 4.872

6.  Identification and functional analysis of 9p24 amplified genes in human breast cancer.

Authors:  J Wu; S Liu; G Liu; A Dombkowski; J Abrams; R Martin-Trevino; M S Wicha; S P Ethier; Z-Q Yang
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

7.  NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.

Authors:  Chen Shen; Jonathan J Ipsaro; Junwei Shi; Joseph P Milazzo; Eric Wang; Jae-Seok Roe; Yutaka Suzuki; Darryl J Pappin; Leemor Joshua-Tor; Christopher R Vakoc
Journal:  Mol Cell       Date:  2015-11-25       Impact factor: 17.970

8.  Development and optimization of piperidyl-1,2,3-triazole ureas as selective chemical probes of endocannabinoid biosynthesis.

Authors:  Ku-Lung Hsu; Katsunori Tsuboi; Landon R Whitby; Anna E Speers; Holly Pugh; Jordon Inloes; Benjamin F Cravatt
Journal:  J Med Chem       Date:  2013-10-23       Impact factor: 7.446

Review 9.  The pur protein family: genetic and structural features in development and disease.

Authors:  Edward M Johnson; Dianne C Daniel; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

Review 10.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.